Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Cervical stiffness test to help predict preterm birth in at-risk pregnant women

Official title: Cervical Stiffness in Women With Threatened Preterm Labor: a Czech Cohort Study

Run by Pregnolia AG · NCT07840235 · Data updated 2026-11-12

A simple cervical stiffness test using the Pregnolia device is being studied to see if it can better identify women with threatened preterm labor who are likely to give birth soon.

More Preterm Birth trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorPregnolia AG
Industry-sponsored
Locations1 site (Prague)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07840235 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women with singleton pregnancies between 22+0 and 35+6 weeks gestation experiencing threatened preterm labor symptoms, and with ultrasound-confirmed closed os and no bulging membranes.

Probably not a fit

Patients with signs of imminent labor or cervical dilation ≥3 cm or membrane bulging are not expected to benefit from this assessment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study evaluating whether measuring cervical stiffness with the Pregnolia System can predict spontaneous preterm birth among women with symptoms of threatened preterm labor. Eligible participants are singleton pregnancies between 22 and 35+6 weeks gestation with signs of potential preterm labor, who have a recent ultrasound confirming closed cervical os and no membrane bulging. The study compares the cervical stiffness measurement to standard clinical assessments to determine its diagnostic accuracy. Findings could help reduce unnecessary hospital admissions and targeted interventions for those truly at risk.

Why it matters

Potential benefit: If successful, the test could improve prediction of imminent preterm birth and guide better, more timely care.

How similar studies have gone: Cervical stiffness measurement with similar approaches has shown promise in predicting spontaneous preterm birth in prior research but is not yet standard practice.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton gestation
* Aged ≥18 years
* Able to give informed consent
* Between 22 weeks, 0 days and 35 weeks, 6 days of gestation
* An ultrasound performed within 6 hours prior to CSI assessment, or after CSI assessment, showing a closed external cervical os and absence of bulging of the membranes into the cervical canal. If ultrasound was conducted by referring hospital, it shall be repeated as part of the study.
* At speculum or vaginal examination: cervical dilation less than 3 cm and no membrane seen or palpated.
* Intact membranes
* Sign and/or symptoms of threatened preterm labor: one or more of the following:

  * Abdominal pain or cramps
  * Uterine contractions, felt or unfelt
  * Bloody show ("spotting" or light bleeding)
  * Pelvic pressure
  * Low back pain (continuous or intermittent)

Exclusion Criteria:

* Signs of imminent labor such as strong, painful and intense contractions (strong suspicion of true labor).
* Cervical dilatation ≥ 3 cm
* Signs of intrauterine infection / amnionitis
* Obstetric indication for immediate delivery (advanced labor, cord prolapse, placenta abruption, signs of fetal distress)
* Confirmed fetal abnormality
* Fetal death
* Known or suspected rupture of membranes
* Confirmed vasa / placenta previa
* Severe active vaginal bleeding
* Light bleeding that cannot be stopped
* Cerclage or pessary in place
* Müllerian anomalies
* Female genital mutilation

Where it's running

  • Institute for the Care of Mother and Child
    Prague, Czechia
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.